Skip To Main Content
Tabarak AlSaadi on Muck Rack

Tabarak AlSaadi

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Tabarak

Contact Tabarak, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Real-world effectiveness and safety of ranibizumab biosimilar FYB-201 in Saudi Arabia (Ravegza) and Jordan (Uptera): a middle eastern extension of the FORCE study

|
By Ashish Sharma, Ahmed Abdelshafy Tabl, Mutasem Elfalah, Heba T. Rihani, Marwa Abdelshafy Tabl, Ahmed A. Shebl, Walid Samir Abousaif, Moayad Shaf”ei, Tabarak AlSaadi
| Nature Verified
Anti-vascular endothelial growth factor (anti-VEGF) therapy has become the standard of care for the management of retinal vascular diseases, including diabetic macular oedema (DMO), neovascular age-related macular degeneration (nAMD), retinal vein occlusion (RVO) and proliferative diabetic retinopathy (PDR), which remain major causes of vision loss worldwide [1].
Open in Who Shared Issue with article?
See all 1 articles